Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The contract biotech company plans to invest around $50 million to buy and renovate a Baltimore facility as it shifts more ...

This week's dividend activity included increased payouts from Advanced Materials (AMAT) and Dick's Sporting Goods (DKS) as ...

Approximately 163 employees will be impacted by the pending closure of Merck's Cherokee plant with layoffs set to begin in ...

In the closing of the recent trading day, Merck (MRK) stood at $94.71, denoting a +1.46% change from the preceding trading day.

Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to ...

A man has claimed his genitals 'shrank and changed shape' after taking a hair loss drug. According to the Wall Street Journal ...

The 5th Medical Device Software Development Summit is your must-attend opportunity to gain actionable strategies, real-world ...